Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Update to the page's revision history showing Revision: v3.6.6, replacing the previous v3.6.5. This reflects a newer platform release entry for this study record history.
    Difference
    0.0%
    Check dated 2026-08-29T18:48:30.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added and the previous Revision: v3.6.4 was removed in the Record History. This indicates a new revision entry for the study record history.
    Difference
    0.0%
    Check dated 2026-08-15T15:34:49.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page's revision tag updates from v3.6.3 to v3.6.4, indicating a minor version update to the record history page.
    Difference
    0.0%
    Check dated 2026-07-25T08:30:11.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The Record History now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor update to the page metadata rather than substantive study information.
    Difference
    0.0%
    Check dated 2026-07-03T22:15:36.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The revision in the history was updated to v3.6.2, replacing the previous v3.6.0. This indicates a small metadata update to the page's revision record.
    Difference
    0.0%
    Check dated 2026-06-26T19:37:44.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants', indicating the study is not seeking participants. A new revision label 'v3.6.0' is added and the previous 'v3.5.5' revision is deleted.
    Difference
    0.1%
    Check dated 2026-06-12T12:17:08.000Z thumbnail image

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.